📰 Nasdaq Mlab News
Nasdaq Mlab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Mlab. Real-time updates on events, politics, business and more.
May 2, 2024
Louisiana State Employees Retirement System bought a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,600 shares of the medical instruments supplier’s stock, valued at approximately $272,000. Several other hedge funds and […]
April 27, 2024
Motley Fool Asset Management LLC boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,709 shares of the medical instruments supplier’s stock after buying an additional 778 shares during the period. […]
April 10, 2024
Conestoga Capital Advisors LLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 578,463 shares of the medical instruments supplier’s stock after purchasing an additional 48,253 shares during the period. Conestoga Capital Advisors LLC owned […]
April 10, 2024
Conestoga Capital Advisors LLC raised its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 578,463 shares of the medical instruments supplier’s stock after buying an additional 48,253 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 0.11% of Mesa Laboratories worth $60,606,000 […]
February 27, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) declared a quarterly dividend on Tuesday, January 2nd, Zacks reports. Stockholders of record on Thursday, February 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend […]
February 24, 2024
Kayne Anderson Rudnick Investment Management LLC cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the […]
February 24, 2024
Kayne Anderson Rudnick Investment Management LLC trimmed its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the period. Kayne Anderson Rudnick Investment Management LLC’s holdings in Mesa Laboratories were […]
February 24, 2024
Kayne Anderson Rudnick Investment Management LLC cut its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares […]
January 26, 2024
Daiwa Securities Group Inc. decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 8.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,603 shares of the medical instruments supplier’s stock after selling 400 shares during the quarter. Daiwa Securities Group Inc. […]
January 4, 2024
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) was upgraded by equities research analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Thursday, Briefing.com reports. The brokerage currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $100.00. […]